SGA
STJ

Strategic Global Advisors’s St Jude Medical STJ Stock Holding History

Strategic Global Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,241
Closed -$262K – 157
2015
Q4 		$262K Buy
4,241
+730
+21% +$46K 0.11% 123
2015
Q3 		$222K Hold
3,511
– – 0.11% 121
2015
Q2 		$257K Hold
3,511
– – 0.15% 121
2015
Q1 		$230K Hold
3,511
– – 0.17% 119
2014
Q4 		$229K Buy
+3,511
New +$226K 0.2% 121

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Strategic Global Advisors's STJ Position: Q1 2016 in Review

Strategic Global Advisors sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 4,241 shares — an estimated $262K sold.

Strategic Global Advisors first reported a position in STJ in Q4 2014 and held it in 5 quarters. The position peaked at $262K in Q4 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • Strategic Global Advisors reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • Strategic Global Advisors sold 4,241 St Jude Medical shares in Q1 2016, an estimated $262K.
  • Strategic Global Advisors first reported a position in St Jude Medical in Q4 2014 and held it in 5 quarters.
  • Strategic Global Advisors's St Jude Medical position peaked at $262K in Q4 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Strategic Global Advisors's 13F filing for Q1 2016, filed 13 May 2016.